Acadia Healthcare (NASDAQ:ACHC) Posts Quarterly Earnings Results, Beats Estimates By $0.14 EPS

Acadia Healthcare (NASDAQ:ACHC) released its quarterly earnings results on Wednesday. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.14, FiscalAI reports. The business had revenue of $895.31 million during the quarter, compared to the consensus estimate of $877.76 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.72 earnings per share.

Acadia Healthcare Stock Performance

NASDAQ:ACHC traded up $2.63 during mid-day trading on Wednesday, hitting $32.25. The stock had a trading volume of 5,055,130 shares, compared to its average volume of 1,622,090. The stock has a market capitalization of $3.00 billion, a price-to-earnings ratio of -2.59, a P/E/G ratio of 9.54 and a beta of 0.64. The company has a 50 day simple moving average of $29.18 and a 200-day simple moving average of $25.91. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $35.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20.

Key Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter adjusted earnings of $0.60 per share, above analysts’ $0.46 estimate, and revenue of $895.3 million, also ahead of expectations. Revenue increased 5.1% year over year. Acadia Healthcare Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: The company raised its full-year 2026 financial guidance; reports described the revised outlook as slightly above expectations. That signals improved confidence in the year’s performance. Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance Acadia Healthcare Exceeds Q3 Expectations
• Positive Sentiment: Same-facility revenue grew 5.2%, supported by a 1.1% increase in patient days and a 4.0% increase in revenue per patient day. Acadia Healthcare Third-Quarter Results
• Negative Sentiment: Despite beating estimates, quarterly earnings per share declined from $0.72 in the year-ago quarter to $0.60, a year-over-year comparison that may temper the positive reaction.

Analyst Upgrades and Downgrades

ACHC has been the subject of several recent analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. Guggenheim increased their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. UBS Group boosted their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. TD Cowen boosted their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, Raymond James Financial downgraded Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 target price on the stock. in a report on Monday, September 28th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $30.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.